Synthesis and structure-activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors

被引：13

作者：

Xu, Yong ^{[1
]}

Foulks, Jason M. ^{[1
]}

Clifford, Adrianne ^{[1
]}

Brenning, Benjamin ^{[1
]}

Lai, Shuping ^{[1
]}

Luo, Bai ^{[1
]}

Parnell, K. Mark ^{[1
]}

Merx, Shannon ^{[1
]}

McCullar, Michael V. ^{[1
]}

Kanner, Steven B. ^{[1
]}

Ho, Koc-Kan ^{[1
]}

机构：

[1] Astex Pharmaceut Inc, Dublin, CA 94568 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 14期

关键词：

PAK1; kinase; 2-Arylamino-4-aryl-pyrimidines; Colon cancer; Pak1; inhibitor; Bioisostere; CANCER-CELLS; P21-ACTIVATED KINASE; EXPRESSION; TARGET; AMPLIFICATION; MECHANISM; CARCINOMA; REVEALS;

D O I：

10.1016/j.bmcl.2013.05.059

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

2-Arylamino-4-aryl-pyrimidines were found to be potent inhibitors of PAK1 kinase. The synthesis and SAR are described. The incorporation of a bromide at the 5-position of the pyrimidine core and in combination with a 1,2-dimethylpiperazine pendant domain yielded a lead compound with potent PAK1 inhibition and anti-proliferative activity in various colon cancer cell lines. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：4072 / 4075

页数：4

共 50 条

[31] Design of Potent and Selective Hybrid Inhibitors of the Mitotic Kinase Nek2: Structure-Activity Relationship, Structural Biology, and Cellular Activity
Innocenti, Paolo
Cheung, Kwai-Ming J.
Solanki, Savade
Mas-Droux, Corine
Rowan, Fiona
Yeoh, Sharon
Boxall, Kathy
Westlake, Maura
Pickard, Lisa
Hardy, Tara
Baxter, Joanne E.
Aherne, G. Wynne
Bayliss, Richard
Fry, Andrew M.
Hoelder, Swen
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3228 - 3241
[32] Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2)
Yu, Le-Mao
Hu, Zhu
Chen, Yu
Ravji, Azhar
Lopez, Sophia
Plescia, Caroline B.
Yu, Qian
Yang, Hui
Abdelmalak, Monica
Saha, Sourav
Agama, Keli
Kiselev, Evgeny
Marchand, Christophe
Pommier, Yves
An, Lin-Kun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 777 - 796
[33] Synthesis, Structure-Activity Relationship and Biological Activity of Acridine Derivatives as Potent MDR-Reversing Agents
Wang, Jianhong
Luo, Tianwei
Li, Shaobin
Zhhang, Yahong
Wang, Chaojie
Zhao, Jin
CURRENT MEDICINAL CHEMISTRY, 2013, 20 (32) : 4070 - 4079
[34] Structure-Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Jia, Yijiang
Jia, Renbo
Taledaohan, Ayijiang
Wang, Yanming
Wang, Yuji
PHARMACEUTICS, 2024, 16 (03)
[35] Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors
Zeng, Debin
Ma, Yuying
Zhang, Rui
Nie, Quandeng
Cui, Zhengjie
Wang, Yaxin
Shang, Luqing
Yin, Zheng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (07) : 1762 - 1766
[36] Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2, 3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors
Huang, Qiang
Zheng, Maofa
Yang, Shuangshuang
Kuang, Chunxiang
Yu, Cunjing
Yang, Qing
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5680 - 5687
[37] Sinapic acid phenethyl ester as a potent selective 5-lipoxygenase inhibitor: Synthesis and structure-activity relationship
Touaibia, Mohamed
Hebert, Martin J. G.
Levesque, Natalie A.
Doiron, Jeremie A.
Doucet, Marco S.
Jean-Francois, Jacques
Cormier, Marc
Boudreau, Luc H.
Surette, Marc E.
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (05) : 1876 - 1887
[38] Synthesis and Structure-Activity Relationship Study of Chemical Probes as Hypoxia Induced Factor-1α/Malate Dehydrogenase 2 Inhibitors
Naik, Ravi
Won, Misun
Ban, Hyun Seung
Bhattarai, Deepak
Xu, Xuezhen
Eo, Yumi
Hong, Ye Seul
Singh, Sarbjit
Choi, Yongseok
Ahn, Hee-Chul
Lee, Kyeong
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (22) : 9522 - 9538
[39] Quantitative Structure-Activity Relationship and Molecular Docking Studies of Imidazolopyrimidine Amides as Potent Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Emami, Leila
Sabet, Razieh
Sakhteman, Amirhossein
Zade, Mehdi Khoshnevis
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2019, 27 (06)
[40] Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARα selective activators- PPARα and PPARγ selectivity modulation
Ye, Xiang-Yang
Chen, Stephanie
Zhang, Hao
Locke, Kenneth T.
O'Malley, Kevin
Zhang, Litao
Srivastava, Raijit
Miao, Bowman
Meyers, Daniel
Monshizadegan, Hossain
Search, Debra
Grimm, Denise
Zhang, Rongan
Lippy, Jonathan
Twamley, Celeste
Muckelbauer, Jodi K.
Chang, Chiehying
An, Yongmi
Hosagrahara, Vinayak
Zhang, Lisa
Yang, T. -J.
Mukherjee, Ranjan
Cheng, Peter T. W.
Tino, Joseph A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2933 - 2937

← 1 2 3 4 5 →